- Home
- TKR vs RYTM Comparison
TKR vs RYTM Comparison
Compare TKR & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKR
- RYTM
- Stock Information
- Founded
- TKR 1899
- RYTM 2008
- Country
- TKR United States
- RYTM United States
- Employees
- TKR N/A
- RYTM N/A
- Industry
- TKR Metal Fabrications
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- TKR Industrials
- RYTM Health Care
- Exchange
- TKR Nasdaq
- RYTM Nasdaq
- Market Cap
- TKR 5.1B
- RYTM 5.9B
- IPO Year
- TKR N/A
- RYTM 2017
- Fundamental
- Price
- TKR $80.98
- RYTM $87.81
- Analyst Decision
- TKR Buy
- RYTM Strong Buy
- Analyst Count
- TKR 10
- RYTM 13
- Target Price
- TKR $79.56
- RYTM $89.77
- AVG Volume (30 Days)
- TKR 604.1K
- RYTM 1.0M
- Earning Date
- TKR 07-30-2025
- RYTM 08-05-2025
- Dividend Yield
- TKR 1.73%
- RYTM N/A
- EPS Growth
- TKR N/A
- RYTM N/A
- EPS
- TKR 4.64
- RYTM N/A
- Revenue
- TKR $4,523,000,000.00
- RYTM $136,863,000.00
- Revenue This Year
- TKR N/A
- RYTM $37.47
- Revenue Next Year
- TKR $3.38
- RYTM $71.16
- P/E Ratio
- TKR $17.40
- RYTM N/A
- Revenue Growth
- TKR N/A
- RYTM 48.88
- 52 Week Low
- TKR $56.20
- RYTM $40.61
- 52 Week High
- TKR $90.49
- RYTM $94.80
- Technical
- Relative Strength Index (RSI)
- TKR 69.85
- RYTM 70.75
- Support Level
- TKR $78.20
- RYTM $86.25
- Resistance Level
- TKR $78.20
- RYTM $92.14
- Average True Range (ATR)
- TKR 1.73
- RYTM 3.66
- MACD
- TKR 0.21
- RYTM 0.59
- Stochastic Oscillator
- TKR 96.97
- RYTM 76.82
About TKR Timken Company (The)
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.